The history of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, producing billions in revenue , its exclusivity period created a flood of lower-priced alternatives , significantly diminishing its dominance. While some businesses may attempt to capitalize on related treatments , the